1. |
葉任高,陸在英.內科學[M].第6版.北京:人民衛生出版社,2005:572-576..
|
2. |
張象麟.藥物臨床信息參考2006[M].第1版.成都:四川科學技術出版社,2006:902-904..
|
3. |
周惠瓊,吳東海,馬麗.短期小劑量甲氨蝶呤導致嚴重不良反應臨床分析[J].中華風濕病學雜志,2002,6(2):135-137..
|
4. |
BASILE C, MONTANARO A, SEMERARO A. Should lowdose methotrexate therapy be prescribed to dialysis patients?[J] Nephrol Dial Transplant,2002,17:530-531..
|
5. |
GUTIERREZURENA S, MOLINA J F, GARCIA C O, et al. Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis[J]. Arthritis Rheum,1996,39:272-276..
|
6. |
BOULANGER H, LAUNAYVACHER V, HIERNIAUX P, et al. Severe methotrexate intoxication in a hemodialysis patient treated for rheumatoid arthritis[J]. Nephrol Dial Transplant,2001,16:1087..
|
7. |
RHEUMATOID ARTHRITIS CLINICAL TRIAL ARCHIVE GROUP. The effect of age and renal function on the efficacy and toxicity of methotrexate in rheumatoid arthritis[J]. J Rheumatol,1995,22:2218-2231..
|
8. |
SEYFFART G. Poison indexthe treatment of acute intoxication[M]. 4th ed. Scottsdale, AZ: Pabst Science Publishers,1997:449-451..
|